根据疾病持续时间调整性结肠炎相关瘤的监测间隔
Ryoya Sakakibara1, Shinya Sugimoto1, Yuta Kaieda1
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
概括
对于长期患有性结肠炎 (UC) 的患者来说,缩短监视结肠镜间隔可能会改善检测结肠炎相关瘤. 这对于20-25年的疾病持续时间的人来说尤其重要.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 临床医学 临床医学
背景情况:
- 性结肠炎 (UC) 增加了结肠炎相关癌症的风险,随着疾病持续时间的增加,风险会升级.
- 目前的监测结肠镜检查方案经常对UC超过8年的患者实施统一的风险分层.
- 这种统一性可能导致长期疾病中瘤的低于最佳检测率.
研究的目的:
- 评估较短的监测间隔是否会提高性结肠炎患者的病变检测率.
- 根据疾病持续时间,评估调整风险分层对瘤检测的影响.
主要方法:
- 2010-2023年间被诊断患有瘤的UC患者的回顾性观察研究.
- 对损伤前检测结肠镜的分析和四个既定的风险分层指南的应用.
- 重新计算推的监测间隔,并比较不同风险类别和疾病持续时间的病变检测率.
主要成果:
- 分析了39名UC患者,疾病持续时间中位数为21年.
- 损伤检测率因指导方针而异 (ASGE:72%,AGA:59%,ECCO:44%,BSG:56%).
- 对较长的疾病持续时间 (≥15,≥20,≥25,≥30年) 进行上升风险分层调整,在所有指南中显著提高了检测率,在20-25年疾病持续时间组中最明显的改善.
结论:
- 减少长期UC的监测间隔可能会改善大肠炎相关新生病的检测.
- 为加强监测,建议将实际重点放在20-25年疾病持续时间的患者身上.
- 优化监测策略对于管理性结肠炎癌症风险至关重要.
相关概念视频
Barrett Esophagus-I: Introduction
224
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
224
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
430
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
430
Inflammatory Bowel Disease V: Surgical Management
225
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
225
Drugs for Treatment of Ulcerative Colitis in IBD
244
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
244
Inflammatory Bowel Disease I: Ulcerative Colitis
345
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
345
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
707
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
707


